Ozempic 2.0 is on the way: The latest on the next wave of weight loss drugs

Ozempic, and the class of weight loss drugs it has come to embody, has left its imprint seemingly everywhere: On the lives of millions of patients who’ve lost unprecedented amounts of weight. On grocery store shelves with new offerings explicitly catering to those taking the drugs. Even in the calculations of insurance companies studying the drugs’ effects on mortality. (Yes, there are Ozempic guides to Thanksgiving.)
For all the societal changes ushered in by GLP-1 drugs, their lofty price tags limit who can affor